What We Do
SPARK Impact is one of the most active investors in the UK. Our focus is building world-class businesses that offer solutions to some of the global challenges that we face . . . Learn more
Portfolio
Here are some of our portfolio companies . . . Learn more
Contact Us
Interested in what we do?
Contact us today for more information . . . Learn more
Brings Patent Portfolio to Five Issued U.S. Patents and over 20+ Pending Patent Applications - Fremont, Calif. and Oxford, UK, November 27, 2018 – Cerus Endovascular Ltd., a privately held medical device company engaged in the design and development of…
Gelmetix's gel can be delivered via a non-invasive procedure into the gaps left by degenerating discs to help restore functionality and relieve lower back pain University of Manchester spin-out company Gelmetix has secured £1.2 funding to help develop its non-surgical…
Fremont, California and Oxford, United Kingdom, November 13, 2018 – Cerus Endovascular Ltd., a privately held medical device company engaged in developing interventional neuroradiology devices and delivery systems to treat acute, life-threatening intracranial aneurysms, today announced enrollment of the first…
Perfect pitch: JA Company Programme student team win ISLEXPO 2018 Pitch It! first prize Posted on 3rd July 2018 by JA Isle of Man Flux, the student team from Queen Elizabeth II High School who took third place in Junior Achievement’s Company of…
Who we work with
